Lornoxicam
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06725 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | rheumatoid arthritis | KG + DL |
| 2 | migraine with or without aura, susceptibility to | KG + DL |
| 3 | migraine disorder | KG + DL |
| 4 | migraine with brainstem aura | KG + DL |
| 5 | brachydactyly-syndactyly syndrome | KG + DL |
| 6 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 7 | headache disorder | KG + DL |
| 8 | trigeminal autonomic cephalalgia | KG + DL |
| 9 | tendinitis | KG + DL |
| 10 | myositis fibrosa | KG + DL |
| 11 | idiopathic granulomatous myositis | KG + DL |
| 12 | fibromyalgia | KG + DL |
| 13 | atrophoderma vermiculata | KG + DL |
| 14 | pulmonary hypertension | KG + DL |
| 15 | ulerythema ophryogenesis | KG + DL |
| 16 | inclusion body myositis | KG + DL |
| 17 | osteoarthritis susceptibility | KG + DL |
| 18 | kyphoscoliotic heart disease | KG + DL |
| 19 | exostosis | KG + DL |
| 20 | gout | KG + DL |
| 21 | Raynaud disease | KG + DL |
| 22 | osteoarthritis | KG + DL |
| 23 | congenital hypotrichosis milia | KG + DL |
| 24 | hypotrichosis simplex of the scalp | KG + DL |
| 25 | diffuse alopecia areata | KG + DL |
| 26 | alopecia | KG + DL |
| 27 | pulmonary hypertension, primary, autosomal recessive | KG + DL |
| 28 | allergic asthma | KG + DL |
| 29 | intrinsic asthma | KG + DL |
| 30 | antithrombin deficiency type 2 | KG + DL |
| 31 | factor 5 excess with spontaneous thrombosis | KG + DL |
| 32 | peripheral vascular disease | KG + DL |
| 33 | exostoses, multiple, | KG + DL |
| 34 | intermittent vascular claudication | KG + DL |
| 35 | WHIM syndrome | KG + DL |
| 36 | bronchial disease | KG + DL |
| 37 | heparin cofactor 2 deficiency | KG + DL |
| 38 | thromboangiitis obliterans | KG + DL |
| 39 | acromesomelic dysplasia, Hunter-Thompson type | KG + DL |
| 40 | myosclerosis | KG + DL |
| 41 | brachyolmia | KG + DL |
| 42 | paratenonitis | KG + DL |
| 43 | arthropathy | KG + DL |
| 44 | calcific tendinitis | KG + DL |
| 45 | brachyolmia-amelogenesis imperfecta syndrome | KG + DL |
| 46 | ankylosing spondylitis | KG + DL |
| 47 | intracranial arteriosclerosis | KG + DL |
| 48 | pseudoachondroplasia | KG + DL |
| 49 | myositis | KG + DL |
| 50 | thrombophilia | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.